Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
Cytarabine (cytosine Arabinoside, Ara-c) Chemotherapy Drug Molecule. Used In Treatment Of Acute Myeloid Leukemia (aml), Acute Lymphocytic Leukemia (all) And Lymphoma. Skeletal Formula. Stock Photo, Picture And Royalty Free Image. Image 93261187.
Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect
Cytarabine (Cytarabine): Uses, Dosage, Side Effects, Interactions, Warning
Sea to Ara C: Appendix
Frontiers | Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements via Multiple Signaling Pathways
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes | Haematologica
Structures of gemcitabine and ara-C (cytarabine). | Download High-Resolution Scientific Diagram
Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Cytarabine - Wikipedia
Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia - Nanoscale (RSC Publishing)